P22: Comparative Analysis of Efficacy of Intravenous Ketamine and Intranasal Esketamine in Treatment-Resistant Depression across Age Groups
Hutchison C, Hermida A, Keshishyan A, Kitay B, Chatham A, Hershenberg R, Posse P, Posse P. P22: Comparative Analysis of Efficacy of Intravenous Ketamine and Intranasal Esketamine in Treatment-Resistant Depression across Age Groups. International Psychogeriatrics 2024, 36: 130-131. DOI: 10.1017/s1041610224002552.Peer-Reviewed Original ResearchBeck Depression InventoryIntravenous ketamineIntranasal esketamineTreatment-resistant depressionRetrospective chart reviewAge groupsResistant depressionClinical responseDepression InventorySymptomatic improvementTreatment resistanceChart reviewEsketamineAcute coursePatientsDepressionKetamineTRDAgeBeckIntranasalInfusionGroupInventory